Clal Insurance’s Evogene EVGN Stock Holding History

Clal Insurance’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Hold	0	–	–	–	228
2021 Q3	–	Hold	0	–	–	–	229
2021 Q2	–	Hold	0	–	–	–	232
2021 Q1	–	Hold	0	–	–	–	225
2020 Q3	–	Sell	-59,126	Closed	-$591K	–	145
2020 Q2	$591K	Hold	59,126	–	–	0.01%	113
2020 Q1	$698K	Buy	59,126 +59,036	+65,596%	+$813K	0.02%	97
2019 Q4	$591K	Sell	90 -59,036	-100%	-$882K	0.63%	42
2019 Q3	$934K	Hold	59,126	–	–	0.02%	93
2019 Q2	$952K	Hold	59,126	–	–	0.02%	84
2019 Q1	$1.08M	Sell	59,126 -872	-1%	-$18.4K	0.03%	78
2018 Q4	$1.19M	Hold	59,998	–	–	0.03%	71
2018 Q3	$1.87M	Hold	59,998	–	–	0.05%	58
2018 Q2	$1.72M	Hold	59,998	–	–	0.04%	56
2018 Q1	$1.91M	Hold	59,998	–	–	0.05%	55
2017 Q4	$1.84M	Hold	59,998	–	–	0.05%	56
2017 Q3	$2.66M	Hold	59,998	–	–	0.06%	53
2017 Q2	$3.04M	Hold	59,998	–	–	0.06%	56
2017 Q1	$3.21M	Hold	59,998	–	–	0.07%	50
2016 Q4	$3.06M	Hold	59,998	–	–	0.06%	50
2016 Q3	$3.83M	Hold	59,998	–	–	0.09%	62
2016 Q2	$3.74M	Hold	59,998	–	–	0.1%	70
2016 Q1	$3.91M	Sell	59,998 -2	-0%	-$137	0.11%	64
2015 Q4	$4.83M	Hold	60,000	–	–	0.13%	60
2015 Q3	$4.95M	Hold	60,000	–	–	0.13%	60
2015 Q2	$5.3M	Hold	60,000	–	–	0.12%	66
2015 Q1	$5.29M	Hold	60,000	–	–	0.12%	70
2014 Q4	$5.53M	Buy	+60,000	New	+$6.36M	0.13%	73

Other funds holding EVGN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EVC

Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Clal Insurance's EVGN Position: Q4 2021 in Review

Clal Insurance held its Evogene (EVGN) position steady in Q4 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #228.

Clal Insurance first reported a position in EVGN in Q4 2014 and has held it in 23 quarters since. The position peaked at $5.53M in Q4 2014. 42 funds tracked by Wall St. Rank hold EVGN as of Q4 2021.

Clal Insurance held 0 shares of Evogene worth $0 as of Q4 2021.
Clal Insurance left its Evogene share count unchanged in Q4 2021.
Evogene made up ﹤0.01% of Clal Insurance's portfolio in Q4 2021, its #228 holding.
Clal Insurance first reported a position in Evogene in Q4 2014 and has held it in 23 quarters since.
Clal Insurance's Evogene position peaked at $5.53M in Q4 2014.
42 funds tracked by Wall St. Rank held Evogene as of Q4 2021.

Based on Clal Insurance's 13F filing for Q4 2021, filed 10 Feb 2022.